nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Bradycardia—Betamethasone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Doxylamine—Bradycardia—Dexamethasone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Doxylamine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Doxylamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Doxylamine—Irritability—Methotrexate—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Doxylamine—Vomiting—Cladribine—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Doxylamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Doxylamine—Mood swings—Methotrexate—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Doxylamine—Rash—Cladribine—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Doxylamine—Hallucination—Betamethasone—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Doxylamine—Hallucination—Dexamethasone—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Doxylamine—Dermatitis—Cladribine—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Doxylamine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Doxylamine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00216	0.00216	CcSEcCtD
Doxylamine—Anorexia—Mitoxantrone—multiple sclerosis	0.00215	0.00215	CcSEcCtD
Doxylamine—Hypotension—Mitoxantrone—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Doxylamine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Doxylamine—Depression—Prednisone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Doxylamine—Erythema—Triamcinolone—multiple sclerosis	0.00209	0.00209	CcSEcCtD
Doxylamine—Erythema—Methylprednisolone—multiple sclerosis	0.00208	0.00208	CcSEcCtD
Doxylamine—Angioedema—Prednisolone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Doxylamine—Breast disorder—Methotrexate—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Doxylamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Doxylamine—Malaise—Prednisolone—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Doxylamine—Nausea—Cladribine—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Doxylamine—Vertigo—Prednisolone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Doxylamine—Eye disorder—Betamethasone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Doxylamine—Eye disorder—Dexamethasone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Doxylamine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Doxylamine—Somnolence—Mitoxantrone—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Doxylamine—Convulsion—Prednisolone—multiple sclerosis	0.00197	0.00197	CcSEcCtD
Doxylamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00196	0.00196	CcSEcCtD
Doxylamine—Fatigue—Mitoxantrone—multiple sclerosis	0.00195	0.00195	CcSEcCtD
Doxylamine—Pancreatitis—Methotrexate—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Doxylamine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00194	0.00194	CcSEcCtD
Doxylamine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Doxylamine—Constipation—Mitoxantrone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Doxylamine—Bradycardia—Prednisone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Doxylamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Doxylamine—Discomfort—Prednisolone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Doxylamine—Angioedema—Triamcinolone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Doxylamine—Angioedema—Methylprednisolone—multiple sclerosis	0.0019	0.0019	CcSEcCtD
Doxylamine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.0019	0.0019	CcSEcCtD
Doxylamine—Erythema—Betamethasone—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Doxylamine—Erythema—Dexamethasone—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Doxylamine—Hallucination—Prednisone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Doxylamine—Malaise—Triamcinolone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Doxylamine—Pancytopenia—Methotrexate—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Doxylamine—Malaise—Methylprednisolone—multiple sclerosis	0.00188	0.00188	CcSEcCtD
Doxylamine—Vertigo—Triamcinolone—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Doxylamine—Vertigo—Methylprednisolone—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Doxylamine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00186	0.00186	CcSEcCtD
Doxylamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Doxylamine—Dizziness—Azathioprine—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Doxylamine—Convulsion—Triamcinolone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Doxylamine—Tachycardia—Prednisolone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Doxylamine—Convulsion—Methylprednisolone—multiple sclerosis	0.0018	0.0018	CcSEcCtD
Doxylamine—Urticaria—Mitoxantrone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Doxylamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Doxylamine—Vomiting—Azathioprine—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Doxylamine—Eye disorder—Prednisone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Doxylamine—Anxiety—Methylprednisolone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Doxylamine—Drowsiness—Methotrexate—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Rash—Azathioprine—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Dermatitis—Azathioprine—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Depression—Methotrexate—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Flushing—Prednisone—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Discomfort—Triamcinolone—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Doxylamine—Discomfort—Methylprednisolone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Doxylamine—Dry mouth—Triamcinolone—multiple sclerosis	0.00174	0.00174	CcSEcCtD
Doxylamine—Angioedema—Betamethasone—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Doxylamine—Angioedema—Dexamethasone—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Doxylamine—Confusional state—Methylprednisolone—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Doxylamine—Immune system disorder—Prednisone—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Doxylamine—Malaise—Dexamethasone—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Doxylamine—Malaise—Betamethasone—multiple sclerosis	0.00171	0.00171	CcSEcCtD
Doxylamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Doxylamine—Vertigo—Dexamethasone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Doxylamine—Vertigo—Betamethasone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Doxylamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Doxylamine—Sweating—Methotrexate—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Doxylamine—Insomnia—Prednisolone—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Doxylamine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Doxylamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Doxylamine—Tachycardia—Triamcinolone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Doxylamine—Nausea—Azathioprine—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Doxylamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Doxylamine—Erythema—Prednisone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Doxylamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Doxylamine—Agranulocytosis—Methotrexate—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Doxylamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Doxylamine—Convulsion—Dexamethasone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Doxylamine—Convulsion—Betamethasone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Doxylamine—Asthenia—Mitoxantrone—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Doxylamine—Anxiety—Dexamethasone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Doxylamine—Anxiety—Betamethasone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Doxylamine—Discomfort—Betamethasone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Doxylamine—Discomfort—Dexamethasone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Doxylamine—Hypotension—Methylprednisolone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Doxylamine—Hepatitis—Methotrexate—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Doxylamine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00156	0.00156	CcSEcCtD
Doxylamine—Urethral disorder—Methotrexate—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Doxylamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Doxylamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Doxylamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Doxylamine—Insomnia—Triamcinolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Doxylamine—Insomnia—Methylprednisolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Doxylamine—Ill-defined disorder—Prednisone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Doxylamine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Doxylamine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Doxylamine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Doxylamine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Doxylamine—Agitation—Prednisone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Doxylamine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Doxylamine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Doxylamine—Tachycardia—Dexamethasone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Doxylamine—Tachycardia—Betamethasone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Doxylamine—Angioedema—Prednisone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Doxylamine—Erythema multiforme—Methotrexate—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Doxylamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Doxylamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Doxylamine—Malaise—Prednisone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Doxylamine—Vertigo—Prednisone—multiple sclerosis	0.00148	0.00148	CcSEcCtD
Doxylamine—Eye disorder—Methotrexate—multiple sclerosis	0.00148	0.00148	CcSEcCtD
Doxylamine—Anorexia—Dexamethasone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Doxylamine—Anorexia—Betamethasone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Doxylamine—Urticaria—Prednisolone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Doxylamine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Doxylamine—Fatigue—Triamcinolone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Doxylamine—Fatigue—Methylprednisolone—multiple sclerosis	0.00147	0.00147	CcSEcCtD
Doxylamine—Hypotension—Betamethasone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Doxylamine—Hypotension—Dexamethasone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Doxylamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Doxylamine—Immune system disorder—Methotrexate—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Doxylamine—Convulsion—Prednisone—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Doxylamine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00143	0.00143	CcSEcCtD
Doxylamine—Rash—Mitoxantrone—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Doxylamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Doxylamine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Doxylamine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Doxylamine—Anxiety—Prednisone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Doxylamine—Insomnia—Dexamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Doxylamine—Insomnia—Betamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Doxylamine—Discomfort—Prednisone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Doxylamine—Erythema—Methotrexate—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Doxylamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Doxylamine—Urticaria—Triamcinolone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Doxylamine—Urticaria—Methylprednisolone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Doxylamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Doxylamine—Decreased appetite—Betamethasone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Doxylamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Doxylamine—Nausea—Mitoxantrone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Doxylamine—Fatigue—Dexamethasone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Doxylamine—Fatigue—Betamethasone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Doxylamine—Nervous system disorder—Prednisone—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Doxylamine—Tachycardia—Prednisone—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Doxylamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Doxylamine—Anorexia—Prednisone—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Doxylamine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00128	0.00128	CcSEcCtD
Doxylamine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Doxylamine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Doxylamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Doxylamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00125	0.00125	CcSEcCtD
Doxylamine—Malaise—Methotrexate—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Doxylamine—Vertigo—Methotrexate—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Doxylamine—Leukopenia—Methotrexate—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Doxylamine—Urticaria—Dexamethasone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Doxylamine—Urticaria—Betamethasone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Doxylamine—Dizziness—Prednisolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Doxylamine—Asthenia—Triamcinolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Doxylamine—Asthenia—Methylprednisolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Doxylamine—Insomnia—Prednisone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Doxylamine—Pruritus—Triamcinolone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Doxylamine—Pruritus—Methylprednisolone—multiple sclerosis	0.0012	0.0012	CcSEcCtD
Doxylamine—Convulsion—Methotrexate—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Doxylamine—Decreased appetite—Prednisone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Doxylamine—Rash—Prednisolone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Doxylamine—Dermatitis—Prednisolone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Doxylamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Doxylamine—Fatigue—Prednisone—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Doxylamine—Discomfort—Methotrexate—multiple sclerosis	0.00116	0.00116	CcSEcCtD
Doxylamine—Constipation—Prednisone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Doxylamine—Confusional state—Methotrexate—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Doxylamine—Dizziness—Triamcinolone—multiple sclerosis	0.00113	0.00113	CcSEcCtD
Doxylamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Doxylamine—Dizziness—Methylprednisolone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Doxylamine—Feeling abnormal—Prednisone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Doxylamine—Asthenia—Dexamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Doxylamine—Asthenia—Betamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Doxylamine—Nervous system disorder—Methotrexate—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Doxylamine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Doxylamine—Nausea—Prednisolone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Doxylamine—Pruritus—Dexamethasone—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Doxylamine—Pruritus—Betamethasone—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Doxylamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Doxylamine—Vomiting—Triamcinolone—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Doxylamine—Vomiting—Methylprednisolone—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Doxylamine—Rash—Triamcinolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Doxylamine—Dermatitis—Triamcinolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Doxylamine—Anorexia—Methotrexate—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Doxylamine—Rash—Methylprednisolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Doxylamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Doxylamine—Urticaria—Prednisone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Doxylamine—Diarrhoea—Betamethasone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Doxylamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Doxylamine—Hypotension—Methotrexate—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Doxylamine—Dizziness—Betamethasone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Doxylamine—Dizziness—Dexamethasone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Doxylamine—Insomnia—Methotrexate—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Doxylamine—Nausea—Triamcinolone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Doxylamine—Nausea—Methylprednisolone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Doxylamine—Dyspnoea—Methotrexate—multiple sclerosis	0.001	0.001	CcSEcCtD
Doxylamine—Somnolence—Methotrexate—multiple sclerosis	0.001	0.001	CcSEcCtD
Doxylamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000992	0.000992	CcSEcCtD
Doxylamine—Vomiting—Betamethasone—multiple sclerosis	0.000983	0.000983	CcSEcCtD
Doxylamine—Vomiting—Dexamethasone—multiple sclerosis	0.000983	0.000983	CcSEcCtD
Doxylamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000978	0.000978	CcSEcCtD
Doxylamine—Rash—Betamethasone—multiple sclerosis	0.000974	0.000974	CcSEcCtD
Doxylamine—Rash—Dexamethasone—multiple sclerosis	0.000974	0.000974	CcSEcCtD
Doxylamine—Dermatitis—Betamethasone—multiple sclerosis	0.000974	0.000974	CcSEcCtD
Doxylamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000974	0.000974	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000971	0.000971	CcSEcCtD
Doxylamine—Fatigue—Methotrexate—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Doxylamine—Asthenia—Prednisone—multiple sclerosis	0.000966	0.000966	CcSEcCtD
Doxylamine—Pruritus—Prednisone—multiple sclerosis	0.000952	0.000952	CcSEcCtD
Doxylamine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000927	0.000927	CcSEcCtD
Doxylamine—Diarrhoea—Prednisone—multiple sclerosis	0.000921	0.000921	CcSEcCtD
Doxylamine—Nausea—Betamethasone—multiple sclerosis	0.000918	0.000918	CcSEcCtD
Doxylamine—Nausea—Dexamethasone—multiple sclerosis	0.000918	0.000918	CcSEcCtD
Doxylamine—Urticaria—Methotrexate—multiple sclerosis	0.000894	0.000894	CcSEcCtD
Doxylamine—Dizziness—Prednisone—multiple sclerosis	0.00089	0.00089	CcSEcCtD
Doxylamine—Vomiting—Prednisone—multiple sclerosis	0.000856	0.000856	CcSEcCtD
Doxylamine—Rash—Prednisone—multiple sclerosis	0.000849	0.000849	CcSEcCtD
Doxylamine—Dermatitis—Prednisone—multiple sclerosis	0.000848	0.000848	CcSEcCtD
Doxylamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000829	0.000829	CcSEcCtD
Doxylamine—Asthenia—Methotrexate—multiple sclerosis	0.000807	0.000807	CcSEcCtD
Doxylamine—Nausea—Prednisone—multiple sclerosis	0.000799	0.000799	CcSEcCtD
Doxylamine—Pruritus—Methotrexate—multiple sclerosis	0.000796	0.000796	CcSEcCtD
Doxylamine—Diarrhoea—Methotrexate—multiple sclerosis	0.00077	0.00077	CcSEcCtD
Doxylamine—Dizziness—Methotrexate—multiple sclerosis	0.000744	0.000744	CcSEcCtD
Doxylamine—Vomiting—Methotrexate—multiple sclerosis	0.000715	0.000715	CcSEcCtD
Doxylamine—Rash—Methotrexate—multiple sclerosis	0.000709	0.000709	CcSEcCtD
Doxylamine—Dermatitis—Methotrexate—multiple sclerosis	0.000709	0.000709	CcSEcCtD
Doxylamine—Nausea—Methotrexate—multiple sclerosis	0.000668	0.000668	CcSEcCtD
